EUVIMEDAtrasti EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

Mobile Health Technology for Personalized Tobacco Cessation Support in Laos (Project Support Laos): A Protocol for a Randomized Controlled Trial (Preprint)

Thanh Cong Bui iD, Phonepadith Xangsayarath iD, Phayvanh Keopraseuth iD, Khatthanaphone Phandouangsy iD, Khamsing Keothongkou iD, Vangnakhone Dittaphong iD, Cate Moriasi iD, Khue-Tu T Doan iD, Shweta Kulkarni iD, Chanthavy Soulaphy iD, Dalouny Xayavong iD, Viengphone Sangxayalath and 5 more

JMIR Research Protocols · 2025

DOI: 10.2196/89916 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, 2025. Written by Thanh Cong Bui and 16 co-authors. Institution: Department of Family and Preventive Medicine, College of Medicine, University of Oklahoma Health Campus, Oklahoma City, OK, United States. Major MEDLINE topics: Tobacco Use Cessation, Telemedicine, Smoking Cessation. 1 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

Tobacco use remains the leading cause of preventable morbidity and mortality in Lao People's Democratic Republic (Lao PDR). Despite the prevalence of cigarette smoking in Lao PDR (51% in men and 7% in women), no national tobacco treatment programs are available. Therefore, the development and evaluation of sustainable tobacco cessation interventions suitable for widespread adoption in Lao PDR are pressing public health needs.

Objective

This project aims to adapt our theoretically and empirically based mobile health (mHealth) technology to help people quit smoking cigarettes in Lao PDR.

Methods

Our mHealth approach includes a fully automated, interactive, personalized, smartphone-delivered intervention for behavioral treatment. This project includes 2 main phases. In the first phase, we use formative research methods to adapt our intervention content to the sociocultural context, language, and communication styles of Laotians. In the second phase, we conduct a randomized controlled trial to evaluate the efficacy of our mHealth intervention. In the trial, adult smokers are recruited through 2 national hospitals: Setthathirath Hospital in Vientiane and Champasak Hospital in Champasak Province.

Participants

(n=500) are randomized to either the standard care (SC; n=250) or automated treatment (AT; n=250) group. SC consists of brief advice to quit smoking delivered by research staff, self-help written materials, and a 2-week supply of nicotine replacement therapy (transdermal patches). AT consists of all SC components plus a fully automated smartphone-based treatment program that involves interactive and personalized proactive messages, images, or videos. The primary health outcome of the trial is biochemically confirmed self-reported 7-day point prevalence abstinence 12 months post study enrollment. Secondary outcomes include abstinence at 3 and 6 months post enrollment.

Results

This study was approved by the ethical review boards of the respective domestic and international institutions. Data collection for the formative phase occurred from January 2022 to May 2023, and data analyses are ongoing. Data collection for the trial phase is ongoing and is expected to be completed by the end of 2026.

Conclusions

If the proposed project is successful, it has the potential to transform health care services for tobacco treatment throughout Lao PDR and, ultimately, to significantly reduce tobacco-induced morbidity and mortality in the country. The AT's potential for widespread adoption and sustainability is enhanced by the direct involvement of Lao governmental stakeholders at multiple national institutes. Furthermore, the US-Lao collaborative work and capacity-building activities in this project will contribute to creating a knowledge base for mHealth research applications and advancing mHealth research capacity in Lao PDR.

Subjects

MeSH terms (MEDLINE)

Tobacco Use CessationTelemedicineSmoking CessationHumansLaosDigital HealthAdultMaleFemaleTobacco Control

Author keywords

Lao People's Democratic RepublicmHealth-based interventionmobile healthsmoking cessationtobacco treatment

Authors and institutions

  • Department of Family and Preventive Medicine, College of Medicine, University of Oklahoma Health Campus, Oklahoma City, OK, United States.
  • TSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Campus, 655 Research Parkway, Suite 400, Oklahoma City, OK, 73104, United States, 1 7134746040.
  • Department of Communicable Disease Control, Ministry of Health of Lao People's Democratic Republic, Vientiane Capital, Lao People's Democratic Republic.
  • Ministry of Health of Lao People's Democratic Republic, Vientiane Capital, Lao People's Democratic Republic.
  • Secretariat of the National Tobacco Control Committee, Ministry of Health of Lao People's Democratic Republic, Vientiane Capital, Lao People's Democratic Republic.
  • Champasak Hospital, Champasak Province, Lao People's Democratic Republic.

ORCID profiles: Thanh Cong Bui, Phonepadith Xangsayarath, Phayvanh Keopraseuth, Khatthanaphone Phandouangsy, Khamsing Keothongkou, Vangnakhone Dittaphong, Cate Moriasi, Khue-Tu T Doan, Shweta Kulkarni, Chanthavy Soulaphy, Dalouny Xayavong, Khanittha Sengdara, Michael S Businelle, Summer G Frank-Pearce, Jennifer I Vidrine, Damon J Vidrine

Funding

  • NCI NIH HHS

Cite

APA

Bui, T. C., Xangsayarath, P., Keopraseuth, P., Phandouangsy, K., Keothongkou, K., Dittaphong, V., Moriasi, C., Doan, K. T., Kulkarni, S., Soulaphy, C., Xayavong, D., Sangxayalath, V., Sengdara, K., Businelle, M. S., Frank-Pearce, S. G., Vidrine, J. I., & Vidrine, D. J. (2025). Mobile Health Technology for Personalized Tobacco Cessation Support in Laos (Project Support Laos): A Protocol for a Randomized Controlled Trial (Preprint). JMIR Research Protocols. https://doi.org/10.2196/89916

Vancouver

Bui TC, Xangsayarath P, Keopraseuth P, Phandouangsy K, Keothongkou K, Dittaphong V, et al. Mobile Health Technology for Personalized Tobacco Cessation Support in Laos (Project Support Laos): A Protocol for a Randomized Controlled Trial (Preprint). JMIR Research Protocols. 2025. doi:10.2196/89916

BibTeX
@article{Bui2025,
  author = {Bui, Thanh Cong and Xangsayarath, Phonepadith and Keopraseuth, Phayvanh and Phandouangsy, Khatthanaphone and Keothongkou, Khamsing and Dittaphong, Vangnakhone and Moriasi, Cate and Doan, Khue-Tu T and Kulkarni, Shweta and Soulaphy, Chanthavy and Xayavong, Dalouny and Sangxayalath, Viengphone and Sengdara, Khanittha and Businelle, Michael S and Frank-Pearce, Summer G and Vidrine, Jennifer I and Vidrine, Damon J},
  title = {Mobile Health Technology for Personalized Tobacco Cessation Support in Laos (Project Support Laos): A Protocol for a Randomized Controlled Trial (Preprint)},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/89916}
}
Start for free →